Grantham, Mayo, Van Otterloo & Co (GMO)
CHX

Grantham, Mayo, Van Otterloo & Co (GMO)’s ChampionX CHX Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CHX Stock Details CHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-902,956
Closed -$26.9M – 625
2025
Q1 		$26.9M Buy
+902,956
New +$26.4M 0.08% 154
2024
Q4 		– Sell
-616,246
Closed -$18.6M – 577
2024
Q3 		$18.6M Buy
616,246
+106,378
+21% +$3.36M 0.06% 204
2024
Q2 		$16.9M Buy
+509,868
New +$17.4M 0.06% 216

Other funds holding CHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CHX Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of ChampionX (CHX) in Q2 2025, closing a stake of 902,956 shares — an estimated $26.9M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CHX in Q2 2024 and held it in 3 quarters. The position peaked at $26.9M in Q1 2025. 368 funds tracked by Wall St. Rank hold CHX as of Q2 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining ChampionX position as of Q2 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 902,956 ChampionX shares in Q2 2025, an estimated $26.9M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ChampionX in Q2 2024 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ChampionX position peaked at $26.9M in Q1 2025.
  • 368 funds tracked by Wall St. Rank held ChampionX as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.